Ozempic Injection, Solution
NDC 50090-8027
Product Information
Ozempic (semaglutide) is a NDA-approved product labeled by A-s Medication Solutions. Semaglutide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. It is supplied as a injection, solution for subcutaneous administration. This product entry covers the primary NDC 50090-8027 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 50090-8027?
What are the uses of this product?
What are Active Ingredients of this product?
- SEMAGLUTIDE .68 mg/mL - A glucagon-like peptide and GLP-1 agonist used to enhance glycemic control of TYPE 2 DIABETES MELLITUS, and for OBESITY MANAGEMENT.
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- SEMAGLUTIDE (UNII: 53AXN4NNHX)
- SEMAGLUTIDE (UNII: 53AXN4NNHX) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- SODIUM PHOSPHATE, DIBASIC, DIHYDRATE (UNII: 94255I6E2T)
- PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
- PHENOL (UNII: 339NCG44TV)
- WATER (UNII: 059QF0KO0R)
Which are the Pharmacologic Classes of this product?
* Please review the full disclaimer at the bottom of this page.